Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | VIMTALABS Vimta Labs Limited Pharma · Small | KPL Kwality Pharmaceuticals Limited Pharma · Small | INDOCO Indoco Remedies Limited Pharma · Small | VENUSREM Venus Remedies Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 46 | 55 | 24 | 60 |
| Verdict | FAIR VALUE | FAIR VALUE | OVERVALUED | UNDERVALUED |
| Style | Financial Turnaround | Premium Compounder | OVERVALUED | Growth at Value |
| Piotroski | 8/9 | 8/9 | 4/9 | 7/9 |
| Valuation | 3/30 | 4/30 | 7/30 | 13/30 |
| Growth | 17/25 | 18/25 | 4/25 | 18/25 |
| Quality | 8/20 | 16/20 | 0/20 | 13/20 |
| Balance Sheet | 9/15 | 9/15 | 5/15 | 8/15 |
| Cash Flow | 4/10 | 4/10 | 7/10 | 4/10 |
| Price | ₹527.85 | ₹2,338.6 | ₹205.86 | ₹1,610.7 |
| P/E | 38.70 | 34.70 | — | 22.00 |
| P/B | 6.83 | 7.10 | 1.96 | 3.41 |
| ROE | 13.50% | 22.80% | -9.42% | 16.80% |
| ROCE | 17.60% | 24.20% | 0.93% | 21.70% |
| Debt / Equity | 0.04 | 0.39 | 1.16 | 0.02 |
| FCF Yield | — | — | 4.89% | — |
| Dividend Y | 0.38% | — | 0.10% | — |
| Altman Z | 8.95 | 7.88 | 2.19 | 8.81 |
| Promoter % | 35.85% | 54.87% | 58.86% | 41.76% |
| Mkt Cap (₹Cr) | 2354.00 | 2356.00 | 1842.00 | 2266.00 |
| Graham # | ₹155.05 | ₹683.63 | — | ₹927.33 |
| Fair PE | 42.0 | 42.0 | 3.2 | 42.0 |
| MoS % | +9.2% | +14.2% | — | +50.1% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startVIMTALABS76
KPL144
INDOCO67
VENUSREM508